Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Sessa Capital IM, L.P. | 1.50M | $20.0M | 8.77% | +948.6K | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.47M | $19.0M | 8.61% | -80.2K | 2026-06-30 |
| BlackRock, Inc. | 1.45M | $19.0M | 8.46% | +242.2K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 730.8K | $9.0M | 4.27% | +104.0K | 2026-06-30 |
| CRCM LP | 583.3K | $7.0M | 3.41% | -- | 2026-06-30 |
| TIG Advisors, LLC | 561.5K | $7.0M | 3.28% | -46.0K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 386.9K | $5.0M | 2.26% | +67.1K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 345.5K | $4.0M | 2.02% | -- | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 310.3K | $4.0M | 1.81% | -39.6K | 2026-06-30 |
| 683 Capital Management, LLC | 300.0K | $4.0M | 1.75% | -- | 2026-06-30 |
